# "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome

> **NCT05305898** · PHASE3 · UNKNOWN · sponsor: **Military Institute od Medicine National Research Institute** · enrollment: 2000 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05305898
- **Lead sponsor:** Military Institute od Medicine National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-08
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305898, ""MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05305898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*